In defense of cygxup,
I think it's totally legitimate to be concerned about CytoGenix's option deal with a just-formed company whose ability to accomplish anything in China and India can't be assessed based on a track record. The fact that this company is incorporated offshore (in the Virgin Islands?) raises additional doubt in a cautious investor's mind.
If you trust CYGX management, these doubts become much less significant, but it takes awhile to establish a degree of trust . . . and if I remember right, even those who've been here for awhile and do trust management expressed some questions about the Phanuel Pursuits deal.
Market Data 
Markets 
AI
